Elucidating the specific pharmacological mechanism of action (MOA) of naturally developing compounds can be difficult. Whilst Tarselli et al. (sixty) formulated the 1st de novo artificial pathway to conolidine and showcased that this naturally occurring compound proficiently suppresses responses to both equally chemically induced and inflammation-d